Results 1 to 10 of about 8,448,017 (179)

Affordability of oncology drugs: accuracy of budget impact estimations

Journal of Market Access & Health Policy, 2020
Background: In many countries, Budget Impact (BI) informs reimbursement decisions. Evidence has shown that decision-makers have restricted access based on high BI estimates but studies show that BI estimates are often inaccurate. Objective: To assess the
Joost W. Geenen, Mark Jut, Cornelis Boersma, Olaf H. Klungel, Anke M. Hövels   +4 more
doaj   +2 more sources

Cost-effectiveness and budget impact of Luspatercept in Thai adults with transfusion-dependent beta-thalassaemia: a multi-state Markov model based on national claims data [PDF]

Journal of Pharmaceutical Policy and Practice
Background Luspatercept is a first-in-class erythroid maturation agent that reduces transfusion burden in adults with transfusion-dependent beta-thalassaemia (TDT). However, its cost-effectiveness has not been evaluated in middle-income settings.
Khachen Kongpakwattana, Peerapon Wong, Nattiya Teawtrakul, Pimlak Charoenkwan, Nilawan Upakdee   +4 more
doaj   +2 more sources

Economic Evaluation of Pneumococcal Vaccination in Egypt: Cost-Effectiveness, Budget Impact, and Domestic Manufacturing Potential [PDF]

Vaccines
Background/Objectives: Streptococcus pneumoniae remains a major cause of morbidity and mortality in Egypt, yet pneumococcal conjugate vaccines (PCVs) are not included in the national immunization program.
Chrissy Bishop, Arnold Hagens, Federico Rodriguez-Cairoli, Konstantina Politopoulou, Zicheng Wang, Motuma Abeshu, Sowmya Kadandale, Ibironke Oyatoye, Saadia Farrukh   +8 more
doaj   +2 more sources

The Energy Budgets of Giant Impacts [PDF]

Journal of Geophysical Research: Planets, 2020
AbstractGiant impacts dominate the final stages of terrestrial planet formation and set the configuration and compositions of the final system of planets. A giant impact is believed to be responsible for the formation of Earth's Moon, but the specific impact parameters are under debate.
Carter, Philip, Lock, Simon, Stewart, Sarah T   +2 more
openaire   +4 more sources

Budget based bonus, budget emphasis, budget gaming, and the impact on budget value [PDF]

Jurnal Keuangan dan Perbankan, 2020
The issue of budget value has received attention and criticism from many researchers, especially that the budget value is not aligned with the sacrifices made in the budgeting process. The purpose of the study is to examine the effect of budget-based bonus and budget emphasis towards budget gaming and its implications on budget value.
Rhaisya Setiawati Rachmat, SeTin SeTin
openaire   +2 more sources

Emicizumab prophylaxis for people with hemophilia A: Waste estimation and the Brazilian perspective

Saudi Pharmaceutical Journal, 2023
Costs of hemophilia A treatment are increasing. Waste of clotting products should be avoided. To estimate the first-year waste of emicizumab prophylaxis for people with hemophilia A and inhibitors (PwHAi) who failed immune tolerance induction (ITI), in ...
Ricardo Mesquita Camelo, Mariana Michel Barbosa, Luila Clicia Moura Henriques, Antony Paul Martin, Brian Godman, Augusto Afonso Guerra Júnior, Francisco de Assis Acurcio, Juliana Alvares-Teodoro   +7 more
doaj   +1 more source

Orphan drugs’ clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement

Frontiers in Pharmacology, 2023
Legislations incentivising orphan drug development and scientific advances have made orphan drugs pharma’s high-end favourite for the past two decades. Currently, around 50% of new marketing authorizations are for orphan drugs. For third-party healthcare
Hans-Georg Eichler, Michael Kossmeier, Markus Zeitlinger, Brigitte Schwarzer-Daum   +3 more
doaj   +1 more source

Pharmacoeconomic aspects of macitentan in the therapy of pulmonary arterial hypertension [PDF]

Терапевтический архив, 2017
Aim. To provide a pharmacoeconomic estimate of macitentan versus bosentan in therapy for pulmonary arterial hypertension (PAH). Subject and methods. An analysis was carried out on the basis of a social perspective for patients, whose mean age was 50 ...
O M Moisseeva, A V Rudakova
doaj   +1 more source

BUDGET IMPACT ANALYSIS OF PERAMPANEL FOR ADJUNCTIVE TREATMENT IN EPILEPSY PATIENTS 12 YEARS OF AGE AND OLDER FOR PARTIAL ONSET SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION AND PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN THE RUSSIAN FEDERATION

Фармакоэкономика, 2016
Objectives. To assess the incremental budget impact (BI) of using of utilizing perampanel to treat partial-onset seizures (POS) and primary generalized tonic-clonic seizures (PGTCS) in patients who are 12 years of age and older in Russia.Methods.
V. R. Mkrtchyan, A. M. Sergeev, K. I. Pochigaeva, I. A. Shpak   +3 more
doaj   +1 more source

Pharmacoeconomic efficacy of atesolizumab compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy

Фармакоэкономика, 2020
Aim: to evaluate the pharmacoeconomic efficacy of the application of the atesolizumab (PD-L1 inhibitor) preparation compared with other control point inhibitors (PD-1 inhibitors) in patients with advanced non-small cell lung cancer (NSCLC) after chemothe
S. K. Zyryanov, I. N. Diyakov
doaj   +1 more source